TrialNeurosurgery2021

A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma.

David M Peereboom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.